Tetsuya Isaka

13PUBLICATIONS

22CO-AUTHORS

Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersLiquid biopsiesMolecular targetsMedical devices

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 24, 2026

Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

|Aug 13, 2025

Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasis.

Tetsuya Isaka, Yohei Miyagi, Rika Kasajima

|Jun 27, 2025

A multi-institutional randomized phase III trial of lobectomy versus segmentectomy for radiologically solid-predominant non-small cell lung cancer with a ground-glass opacity and tumor diameter > 2 cm and ≤ 3 cm: JCOG2217 (STRONG).

Noriko Mitome, Aritoshi Hattori, Kenji Suzuki

|Mar 04, 2025

Comparison of the Changes in Visceral Adipose Tissue After Lobectomy and Segmentectomy for Patients With Early-Stage Lung Cancer.

Tetsuya Isaka, Takuya Nagashima, Kota Washimi

|May 03, 2024

Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancer.

Naoko Shigeta, Shuji Murakami, Tomoyuki Yokose

|Feb 23, 2024

Right S3 segmentectomy for lung cancer with partial anomalous pulmonary venous return in the right upper pulmonary vein: A case report.

Tetsuya Isaka, Takuya Nagashima, Kotaro Murakami

Pageof 3

Frequent Collaborators

Hiroyuki Ito

Kenji Suzuki

Naoko Shigeta

Tomoyuki Yokose

Kanako Shinada

Tomohiro Miyoshi

Noriko Mitome

Takahiro Mimae

Haruhiro Saito

Shuji Murakami

Frequent Collaborators

Hiroyuki Ito

Kenji Suzuki

Naoko Shigeta

Tomoyuki Yokose